Eugia Us LLC — Lidocaine HCl Injection recall — Low risk

Home › Medicine › Eugia Us LLC

Eugia Us LLC

Low risk

The FDA considers this unlikely to cause harm. Return it for a refund if you would rather not keep it.

Class III

Unlikely to cause any adverse health consequence, but the product breaks FDA rules.
Refunds don't require a receipt, and you don't need proof of purchase.
FDA status: Ongoing.

What was recalled

Source: FDA · synced 29 Jul 2026 13:14

Low risk Filed 2026-06-10

Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan

Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520. NDC: 55150-164-02

Check these codes: Lot, expiry: Lot 3LC26029A, exp Feb-2029; Lot 3LC26031A, exp Mar-2029

168,300 vials · distributed us nationwide. Recall D-0552-2026 on FDA.gov ↗

Watch Eugia Us LLC for new recalls

One email per recall. Nothing else, ever.